<DOC>
	<DOCNO>NCT00247793</DOCNO>
	<brief_summary>Effect two preoperative oral immune-enhancing nutritional supplement patient high risk infection cardiac surgery : randomize placebo-controlled study . Introduction : In first study show use preoperative oral immune-enhancing nutritional supplement ( OIENS ) result improved patient ’ host-defence reduction postoperative infectious morbidity ‘ high-risk ’ cardiac surgery patient . The use OIENS result also less postoperative organ dysfunction . Experimental study show additional glycine result less ischemia-reperfusion damage glycine anti-inflammatory property . Objective : The use OIENS preoperative period patient high risk infection elective cardiac surgery use cardiopulmonary bypass ( CPB ) result reduction infection first study . The addition 9.6 gram glycine per sachet OIENS result reduction postoperative dysfunction . Design : A prospective randomize placebo control study two oral immune enhance nutritional formula ’ isocaloric control formula . Patients : Seventy-four consecutive patient undergo cardiac surgery use CPB meet one follow inclusion criterion : Age 70 year old , mitral valve replacement cardiac ejection fraction le 40 % . Exclusion criterion age &lt; 18 year , proven malignancy , use corticosteroid , severe renal liver failure . Definition protocol violation intake less 5 L 10 L nutritional supplement preoperative period . Intervention : Patients split three group conceal randomisation . One group receive arginine , omega3-PUFAs nucleotide enrich formula ( OIENS ) . Another group receive OIENS enrich glycine ( OIENS+glyc ) . The control group receive isocaloric nutritional supplement without enrichment .</brief_summary>
	<brief_title>Immunonutrition Cardiac Surgery</brief_title>
	<detailed_description>Objective To study effect two preoperative immune enhance nutritional supplement compare control nutritional supplement 'high risk ' risk cardiac surgery patient Introduction : Elderly patient patient poor ventricular function undergoing cardiac operation hypothermic cardiopulmonary bypass ( CPB ) , increase postoperative morbidity mortality . Host defence may diminish due nutritional deficiency , hypoperfusion , anaesthesia operative trauma . Immune function additionally depress use CPB hypothermia . It suggest L-arginine improve postoperative outcome cardiac surgery patient , glycine may role protect tissue insults ischemia-reperfusion hypoxia , omega-3 polyunsaturated fatty acid ( omega3-PUFA 's ) limit postoperative generalise inflammatory response . Experimental study show use nutritional supplement contain L-arginine , omega3-PUFA 's nucleotide , boost immune responsiveness surgery trauma . L-arginine semi-essential amino acid precursor nitrous oxide ( NO ) , important endothelial vasodilator . In experimental study , L-arginine improve wound healing , restore postoperative depressed macrophage function lymphocyte responsiveness augment resistance infection . Arginine protect ischemia-reperfusion injury increase oxygen delivery upon reflow , thereby improve cardiac function . The intake additional omega3-PUFA 's alters cell membrane phospholipid content prostaglandin synthesis . This might important factor limit generalise inflammatory response subsequent immunosuppression capillary leakage follow major surgery . Purines pyrimidines essential nutrient rapidly divide cell . The administration nucleotides form yeast-RNA improve host immune response infectious challenge . In experimental study glycine proven cytoprotective stomach , kidney , liver cardiovascular system . The metabolic response oral glycine facilitates uptake op glucose circulation . The immunonutrients , arginine , omega3-PUFA ’ yeast-RNA , combine single oral immune enhance nutritional supplement ( OIENS ) . In cancer surgery , trauma critically ill patient ‘ post event ’ nutrition immune enhance formula improve immunocompetence , reduce infection shorten length stay hospital ( LOSH ) . The onset effect postoperative immune enhance nutrition start 3 day seem dose dependent . For reason , hypothesise may beneficial commence oral immune enhance nutritional supplement ( OIENS ) surgery . A recent publish clinical trail show OIENS three immunonutrients high risk cardiac surgery patient improve preoperative clinical relevant immunological parameter , reduce postoperative infectious morbidity attenuate postoperative organ dysfunction . Recently , three immunonutrients combine glycine new single OIENS . Aim present study ‘ high risk ’ cardiac surgery patient determine whether intake new OIENS minimally five day improve preoperative host defence subsequently reduce postoperative infection organ dysfunction . Study design : A prospective randomize placebo-controlled three arm double blind study Setting : Departments cardiopulmonary surgery , anesthesiology intensive care Academic Medical Center , Amsterdam , The Netherlands Patients : Eligible patient include study obtain write informed consent Inclusion criterion : Patients meet one inclusion criterion : age 70 year , undergo cardiac surgery use CPB , patient poor leave ventricular function ( Ejection fraction &lt; 0.40 ) patient undergo mitral valve replacement . Exclusion criterion : Age &lt; 21 year , pregnancy , insulin dependent diabetes mellitus , hepatic cirrhosis , know malignancy , use chemotherapy , NSAIDs ( exclude acetyl salic acid ) corticosteroid , schizophrenia , severe renal insufficiency ( creatinine clearance &lt; 25 mL/h ) , patient organ transplantation past Randomization : 74 patient randomize closed envelop method Intervention : All patient receive one three enteral nutritional supplement . A formula enrich arginine , omega-3 PUFA 's nucleotide enrich formula enrich additional glycine control formula . Patients need postoperative enteral nutritional support receive formula preoperative . Patients need postoperative enteral nutrition nasogastric tube feed receive nutritional supplement Endpoints : Patient compliance , infection , postperfusion phenomenon , post-operative organ function ( need postoperative support e.g . inotropic , vasopressor support , fluid , myocardial infarction , ventilation parameter , renal function ) time recovery , mortality</detailed_description>
	<criteria>Patients undergo cardiac surgery use cardiopulmonary bypass , meet one follow criterion age &gt; = 70 year poor leave ventricular function ( ejection fraction &lt; 0.4 ) mitral valve replacement Age = &lt; 21 year Pregnancy Insulin dependent diabetes mellitus Hepatic Cirrhosis Known malignancy Use chemotherapy , NSAIDs ( except ASA ) , corticosteroid Schizophrenia Severe renal failure ( creatinine clearance &lt; 25 mL/h ) study entrance Patients organ transplantation past</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>immunonutrition</keyword>
	<keyword>preoperative optimization</keyword>
	<keyword>preoperative enteral nutritional supplement</keyword>
	<keyword>high risk</keyword>
	<keyword>cardiac surgery</keyword>
	<keyword>arginine</keyword>
	<keyword>omega-3 polyunsaturated fatty acid</keyword>
	<keyword>nucleotide</keyword>
	<keyword>glycine</keyword>
	<keyword>immune enhance nutritional supplement</keyword>
	<keyword>immune enhance formula</keyword>
</DOC>